fomesafen has been researched along with cilostazol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiyama, T; Ninomiya, S; Shintani, S; Suzuki, S; Toba, Y; Umezato, M | 1 |
| Abe, A; Hagiwara, H; Katayama, Y; Katsura, K; Nishiyama, Y; Okubo, S; Ueda, M | 1 |
1 trial(s) available for fomesafen and cilostazol
| Article | Year |
|---|---|
Administration of cilostazol, an antiplatelet, to patients with acute-stage cerebral infarction and its effects on plasma substance P level and latent time of swallowing reflex.
Topics: Acute Disease; Aged; Aged, 80 and over; Cerebral Infarction; Cilostazol; Deglutition; Female; Humans; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Reflex; Substance P; Tetrazoles; Time Factors; Treatment Outcome | 2013 |
1 other study(ies) available for fomesafen and cilostazol
| Article | Year |
|---|---|
General pharmacological properties of cilostazol, a new antithrombotic drug. Part I: Effects on the central nervous system.
Topics: Analgesics; Animals; Anticonvulsants; Avoidance Learning; Azoles; Body Temperature; Cats; Central Nervous System; Cilostazol; Electroencephalography; Fibrinolytic Agents; Male; Mice; Mice, Inbred Strains; Motor Activity; Rabbits; Rats; Rats, Inbred Strains; Reflex; Reserpine; Sleep; Tetrazoles; Vasodilator Agents | 1985 |